REGENXBIO Inc.
Nasdaq · Healthcare · Biological Products, (No Diagnostic Substances) · Rockville, MD
RGNX chart
What traders are saying about $RGNX
Latest postsREGENXBIO Inc. news
- Why (RGNX) Price Action Is Critical for Tactical Trading
Stock Traders Daily ·
- REGENXBIO stock: Bank of America sets USD 15.00 target for REGENXBIO stock
ad-hoc-news.de ·
- REGENXBIO Inc. Estimates – NASDAQ:RGNX
TradingView ·
- REGENXBIO Eyes Q4 Pivotal Readout for One-Time Wet AMD Gene Therapy
marketbeat.com ·
- BofA Securities Maintains Regenxbio(RGNX.US) With Buy Rating, Maintains Target Price $15
Moomoo ·
- REGENXBIO to Host Investor Event Highlighting Surabgene Lomparvovec (Sura-vec) in Wet AMD on October 20
Yahoo Finance ·
- Microsoft upgraded, HubSpot downgraded: Wall Street's top analyst calls
Yahoo Finance ·
- Regenxbio’s Two Lead Gene Therapies Back Mizuho’s Nearly 200% Upside Call
stocktwits.com ·
- Regenxbio stock gains on positive gene therapy trial data
Yahoo Finance ·
- REGENXBIO Presents Positive Three-Year Durability Data for Surabgene Lomparvovec in Diabetic Retinopathy at Retina Society Annual Scientific Meeting
Yahoo Finance ·
- REGENXBIO to Participate in Upcoming Investor Conferences
Yahoo Finance ·
- Regenxbio’s Gene Therapy Faces Another FDA Setback in Hunter Syndrome
Yahoo Finance ·
REGENXBIO Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $170.4M | $83.3M | $90.2M | $112.7M |
| Net income | -$193.9M | -$227.1M | -$263.5M | -$280.3M |
| Diluted EPS | $-3.76 | $-4.59 | $-6.02 | $-6.50 |
| Total assets (year end) | $453.0M | $466.0M | $574.0M | $833.3M |
| Cash and equivalents (year end) | $34.5M | $57.5M | $34.5M | $97.0M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About REGENXBIO Inc.
- Ticker
- RGNX (Nasdaq)
- Industry
- Biological Products, (No Diagnostic Substances)
- Headquarters
- Rockville, MD
- Fiscal year end
- December 31
- SEC CIK
- 1590877
- Former names
- ReGenX Biosciences, LLC
Frequently asked questions
What exchange is REGENXBIO Inc. listed on?
REGENXBIO Inc. trades on the Nasdaq under the ticker symbol RGNX.
What industry is REGENXBIO Inc. in?
REGENXBIO Inc. is classified by the SEC under "Biological Products, (No Diagnostic Substances)", part of the Healthcare sector on StockTweeting.
Where is REGENXBIO Inc. headquartered?
REGENXBIO Inc.'s business address on file with the SEC is in Rockville, MD.
When does REGENXBIO Inc.'s fiscal year end?
REGENXBIO Inc.'s fiscal year ends on December 31.
How much revenue did REGENXBIO Inc. report?
REGENXBIO Inc. reported $170.4M in revenue for calendar year 2025, according to its SEC filings.